申请人:Astellas Pharma Inc
公开号:US08273745B2
公开(公告)日:2012-09-25
The present invention relates to a novel compound or a salt thereof, which is useful as a CRTH2 antagonist, especially as a medicament for disorder that participates eosinophil, for example, allergic disorder such as asthma, allergic rhinitis, allergic dermatitis, conjunctival inflammation, hives, eosinophilic bronchitis, food allergy, inflammation of the nasal sinuses, multiple sclerosis, angiitis, or chronic obstructive pulmonary disease (COPD) and the like.
本发明涉及一种新型化合物或其盐,其作为CRTH2拮抗剂具有用途,特别是作为参与嗜酸性粒细胞的疾病的药物,例如过敏性疾病,如哮喘,过敏性鼻炎,过敏性皮炎,结膜炎,荨麻疹,嗜酸性支气管炎,食物过敏,鼻窦炎炎症,多发性硬化症,血管炎或慢性阻塞性肺疾病(COPD)等。